CEVA, Inc. (CEVA) Cash Flow Statement
CEVA, Inc. (CEVA) generated $3.8M of operating cash flow over the twelve months to 2026-06-30, spent $4.9M on capital expenditure and had free cash flow of -$1.1M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CEVACEVA, Inc.Follow CEVA — free
—
Price chart with a free account
- Market cap
- 805.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 27.1 | 18.6 | 13.7 | 9.1 | 19.4 | 14.5 | 24.5 | 8.6 | 9.7 | 15.2 | 25.8 | 6.9 | -6.3 | 3.5 | -3.4 | 3.8 | |
| Capital expenditure | 0.4 | 0.7 | 0.9 | 1.4 | 2.2 | 2.4 | 4.1 | 3.3 | 3.5 | 2.9 | 2.2 | 3.5 | 2.9 | 3.7 | 2.9 | -4.9 | |
| Free cash flow | 26.7 | 17.9 | 12.8 | 7.7 | 17.2 | 12.1 | 20.3 | 5.3 | 6.2 | 12.2 | 23.6 | 3.4 | -9.2 | -0.2 | -6.3 | -1.1 | |
| Share repurchases | — | 27.2 | 19.8 | 18.7 | 10.1 | 3.4 | 0.0 | 20.0 | 9.1 | 4.8 | 0.0 | 6.8 | 6.2 | 8.5 | 7.2 | — | |
| Stock-based compensation | 5.2 | 5.1 | 5.9 | 5.0 | 4.0 | 6.2 | 8.7 | 10.4 | 10.7 | 13.6 | 13.1 | 14.5 | 16.2 | 15.6 | 19.8 | — |
USD millions · SEC XBRL
CEVA, Inc. — questions
- What is CEVA, Inc.'s operating cash flow?
- $3.8M over the twelve months to 2026-06-30.
- How much does CEVA, Inc. spend on capital expenditure?
- $4.9M over the twelve months to 2026-06-30.
- What is CEVA, Inc.'s free cash flow?
- -$1.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from CEVA, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.